BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 96 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $781,966 | -27.8% | 41,906 | -16.9% | 0.02% | -36.0% |
| Q4 2022 | $1,083,666 | -51.9% | 50,450 | -53.2% | 0.02% | -51.9% |
| Q1 2022 | $2,252,000 | +977.5% | 107,700 | +1398.7% | 0.05% | +642.9% |
| Q2 2021 | $209,000 | -88.0% | 7,186 | -78.1% | 0.01% | -94.1% |
| Q2 2020 | $1,742,000 | -8.5% | 32,865 | -61.4% | 0.12% | -24.7% |
| Q1 2020 | $1,903,000 | +395.6% | 85,154 | +224.3% | 0.16% | +378.8% |
| Q4 2019 | $384,000 | – | 26,255 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |